Open letter to Lamberto Andreotti, Chief Executive Officer, Bristol-Myers Squibb.
Kamal-Yanni
Mohga
M
Nichols
Kim
K
Tallah
Esther
E
Otwoma
Nelson
N
D017954:Africa South of the Sahara; D019380:Anti-HIV Agents / Q000600:supply & distribution*; D003906:Developing Countries; D016049:Didanosine / Q000600:supply & distribution*; D004345:Drug Industry; D005602:France; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D007223:Infant
D019380:Anti-HIV Agents; D016049:Didanosine